Kinesio Taping Technique Versus Virtual Reality in Patients With Chronic Shoulder Impingement Syndrome

November 1, 2022 updated by: Hend Ali Mohamed, Cairo University

Kinesio Taping Technique Versus Virtual Reality in Rehabilitation of Patients With Chronic Shoulder Impingement Syndrome

Purpose of the Study: to compare between the effect of kinesio taping technique versus virtual reality technique in rehabilitation of patients with chronic shoulder impingement syndrome.

Study Overview

Detailed Description

Rotator cuff disorders are considered to be among the most common causes of shoulder pain and disability encountered in both primary and secondary care, with subacromial impingement syndrome in particular being the most common disorder, resulting in functional loss and disability, of the shoulder.

There is a lack of literature about virtual reality exergaming in subjects with orthopedic problems.

To reduce UL impairment, new therapeutic approaches, such as constraint-induced movement therapy, robotic arm training, and virtual reality therapy (VRT), have been successfully employed over the last decade.

Kinesio taping is the increasingly popular method for preventing and treating sports injuries. The tape helps to maintain the joint position, increases the proprioceptive awareness, and assists in removal of exudates thereby reducing pain and improves the muscle function.

So as there is lag in literature regarding the best type of treatment for patients with chronic impingement syndrome so this study will be conducted to compare between kinesiotaping and virtual reality and to determine the best treatment for patients with chronic Shoulder Impingement Syndrome (SIS).

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dokki, Egypt, 35111
        • Outpatient clinic, Faculty of Physical Therapy, Cairo University, Egypt.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

23 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. Patients will be diagnosed with chronic shoulder impingement syndrome (who had supraspinatus tendinitis stage (II) 2. Ages 25-40 years 3. Both sexes will be included. 4. Patients complaint from limitation in the ROM in abduction flexion and external rotation.

    5. Patient complaint from pain and tendinitis in subacromial area more than 3 in VAS.

    6. All patients complaint from difficulties in joining ADL activities. 7. All patients will assign written consent form.

Exclusion Criteria:

Subjects with the following criteria will be excluded from the study:

  1. Shoulder fracture or instability.
  2. Previous shoulder surgery.
  3. Arthritis of the glenohumeral or acromioclavicular joints.
  4. Cervical radiculopathy
  5. Patients with visual disorders.
  6. Diabetic patients.
  7. Balance and coordination disorders.
  8. Tumor and breast cancer.
  9. Major trauma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinsiotaping
patients who received kinesiotaping plus conventional treatment for chronic shoulder impingement syndrome.
Patients received the kinesiotaping over supraspinatus muscle and deltoid muscle, tape will be removed every three days and subjects will return back to the clinic to reapplication of tape again. Patients received the same therapeutic treatment 3 times/ week for four weeks. KT is air permeable and water resistant, allowing it to stay in place for three to five days.
patients received conventional treatment for chronic shoulder impingement syndrome only.
Experimental: Virtual Reality training
patients who received VR training plus conventional treatment for chronic shoulder impingement syndrome.
patients received conventional treatment for chronic shoulder impingement syndrome only.
Virtual Rehab utilizes the unique characteristics of Microsoft Kinects motion technology to track and capture the movements of the patients so that patients become immersed in a 3D environment where they interact with the game. Subjects will include in a supervised virtual reality exergaming program for shoulder movements for 4 weeks, 3 days per week and 10 minutes for session.
Active Comparator: conventional treatment
patients who received conventional treatment for chronic shoulder impingement syndrome only.
patients received conventional treatment for chronic shoulder impingement syndrome only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessing the change in musculoskeletal disorders of the upper limbs
Time Frame: at baseline and after 4 weeks of intervention

Assessment by using Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH). The DASH is a 30-item self-report questionnaire designed to assess musculoskeletal disorders of the upper limbs. Scoring the DASH 30-item disability/symptom section:

1) Item responses range from 1 (e.g. no difficulty, not at all, not limited, none, strongly disagree) to 5 (e.g. unable, extremely, unable, strongly agree). Scoring the optional 2 4-item high performance sections: 1) Add values of each response, then divide by 4, subtract 1 and multiply by 25: [((sum of values/4) - 1)*25]. 2) Optional modules should not be scored if items are missing. Arabic version of DASH questionnaire will be used, Which is reliable and valid to be used for evaluating upper extremity work related injuries.

at baseline and after 4 weeks of intervention
Assessing the change in pain intensity
Time Frame: at baseline and after 4 weeks of intervention
Assessment by using visual analouge scale (VAS). It was used to assess the intensity of pain. Operationally a VAS is usually a horizontal line, l00 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.
at baseline and after 4 weeks of intervention
Assessing the change in shoulder range of motion
Time Frame: at baseline and after 4 weeks of intervention
Assessment by using Electro goniometer. It was used to measure shoulder ROM (flexion, abduction, internal rotation).
at baseline and after 4 weeks of intervention
Assessing the change in muscle activity of Supraspinatus muscle
Time Frame: at baseline and after 4 weeks of intervention
Assessment by using Electromyogram (EMG). It was used to measure muscle activity of Supraspinatus, infraspinatus, anterior and middle deltoid.
at baseline and after 4 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hend Ahmed, Physiotherapist, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

January 1, 2022

Study Completion (Actual)

June 1, 2022

Study Registration Dates

First Submitted

November 1, 2022

First Submitted That Met QC Criteria

November 1, 2022

First Posted (Actual)

November 7, 2022

Study Record Updates

Last Update Posted (Actual)

November 7, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Impingement Syndrome, Shoulder

Clinical Trials on Kinsiotaping

3
Subscribe